For example, it is plausible that other ILC subsets, including pathogenic IFNγ-secreting ILC1, are similarly triggered by neuropeptides, which would provide a source of therapeutic targets for IBD (Bernink et al., 2013). The gene discussed is CCL27; the disease is inflammatory bowel disease.